Valion Bio, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $1.6M
- Price
- $0.49
- % Change (Daily % change from the live per-ticker quote feed.)
- -4.39%
- Volume
- 34.4K
Quote data as of 6:15 AM ET
About
Vitality Biopharma, Inc. specializes in creating cannabinoid-based pharmaceuticals, primarily focusing on addressing inflammatory disorders within the United States. Its current pipeline includes tetrahydrocannabinol glycoside, identified as VBX-100, an orally administered cannabinoid prodrug engineered to combat inflammatory bowel disease (IBD) and irritable bowel syndromes (IBS). Established in 2007, the company originally operated as Stevia First Corp. before officially rebranding as Vitality Biopharma, Inc. in July 2016. Its corporate headquarters are situated in Los Angeles, California.
Quick stats
Shares outstanding3.2M
Computed float3.2M
Float sourceUnknown
Cash runway (months)Unknown
Dilution risk—
Has warrants—
Has convertibles—
Active shelf (Shelf registration (e.g. Form S-3) currently in effect — the company is pre-cleared to issue and sell new shares quickly. A standing dilution risk.)—
Active ATM (At-the-market offering — a program to sell newly issued shares directly into the open market at prevailing prices, diluting existing holders over time.)—
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001787740